Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
This is a Phase 3 clinical trial update examining androgen-deprivation therapy with radiation therapy for prostate cancer. The study is curr…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer [Phase 2]
Phase 2 trial comparing 18F-rhPSMA-7.3 PET/CT with and without furosemide in biochemical recurrence of prostate cancer; results have been po…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy [Phase 2]
Phase 2 randomized trial evaluating salvage radiation therapy plus enzalutamide after prostatectomy for prostate cancer; results have been p…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate [NA]
The trial evaluating the OmnEcoil system for integrated endorectal MRI and MRI-targeted biopsy in prostate cancer has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer [NA]
This clinical trial update notes an active, not-recruiting study at the University of Miami comparing extended versus accelerated radiation …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Nivolumab in Biochemically Recurrent dMMR Prostate Cancer [Phase 2]
A Phase 2 trial of nivolumab in biochemically recurrent, mismatch repair-deficient prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: CYTALUX™for the Intraoperative Imaging of Prostate Cancer [Phase 2]
Phase 2 clinical trial update reporting the completion of a study evaluating CYTALUX as an intraoperative imaging agent for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Zanzalintinib in Men With Aggressive Variant Prostate Cancer [Phase 2]
A Phase 2 clinical trial of Zanzalintinib for aggressive variant prostate cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update on salvage oligometastasectomy and radiation therapy for recurrent prostate cancer with oligometastatic diseas…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Gadopiclenol in Contrast Enhanced MRI of the Prostate [Phase 4]
Phase 4 clinical trial evaluating gadopiclenol as a contrast agent for MRI in prostate cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression [EARLY_Phase 1]
This early Phase 1 trial update reports results from an investigation of an androgen receptor partial agonist in prostate cancer patients on…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC [Phase 1]
Phase 1 study evaluating Acapatamab in metastatic castration-resistant prostate cancer reports safety, tolerability, pharmacokinetics, and p…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide [Phase 2]
Phase 2 ARAMON study comparing darolutamide with enzalutamide to evaluate the effect on testosterone levels in men with biochemically recurr…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy [NA]
A completed clinical trial evaluated whether Vitamin B6 (pyridoxine) can reduce hot flashes in men with prostate cancer undergoing antiandro…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). [Phase 2]
Phase 2 ARROW trial comparing I-131-1095 radioligand plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies [Phase 1, Phase 2]
This Phase 1/2 trial assesses a combination of Avelumab, Utomilumab, and anti-OX40 PF-04518600 with radiation therapy in patients with advan…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer [Phase 3]
A Phase 3 trial comparing 177Lu-PSMA-617 with androgen receptor-directed therapy for progressive metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completion of a real-world intensive monitoring study evaluating the use of olaparib in Chinese patients with ovarian or prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway [Phase 2]
This document reports on a completed Phase 2 trial evaluating the efficacy of carboplatin in metastatic prostate cancer with homologous reco…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation
This completed study from Karolinska Institutet assesses whether PSA-based screening influences mortality in men aged 75-79 using target tri…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. [Phase 1]
A Phase 1 trial evaluating lower dosing regimens of abiraterone (500 mg) in men with prostate cancer to identify the lowest recommended dose…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Abemaciclib With or Without Atezolizumab for mCRPC [Phase 2]
This Phase 2 trial evaluates abemaciclib with or without atezolizumab in metastatic castration-resistant prostate cancer, with results poste…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention [NA]
This ClinicalTrials.gov entry reports the completed status of the PROWESS pilot trial evaluating a wearables, exercise, and structured-suppo…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer [Phase 2]
A Phase II randomized trial is evaluating short-term darolutamide in combination with radiation therapy for patients with intermediate unfav…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: The Effect of 360° Virtual Reality Movies on Fear and Anxiety [NA]
Maastricht Radiation Oncology completed a trial evaluating whether 360° virtual reality movies can reduce fear and anxiety in cancer patient…